Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Naoki Katsumata"'
Autor:
Kenji Miyata, Xuchen Zhou, Tohru Yamawaki, Hiroaki Shimokawa, Kensuke Egashira, Akira Takeshita, Ikuko Kunihiro, Naoki Katsumata, Taiki Higo, Eriko Tanaka
Publikováno v:
Circulation. 100:1432-1437
Background —The question of whether or not endothelial vasodilator function in the spastic coronary artery is preserved is still controversial. We recently developed a porcine model in which long-term and local treatment with interleukin-1β (IL-1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::271992056611297d34a618bcd6298b1c
https://doi.org/10.1161/01.cir.100.13.1432
https://doi.org/10.1161/01.cir.100.13.1432
Publikováno v:
Cardiovascular Drugs and Therapy. 6:611-622
In beagle dogs anesthetized with enflurane-nitrous oxide, effects of sodium nitroprusside (SNP; MR7S1) and nitroglycerin (NTG) on hemodynamics and main organ circulation were studied to evaluate their effectiveness and safety as hypotensive agents du
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca4fa72894b6a690fdec71466ba6709b
https://doi.org/10.1007/bf00052563
https://doi.org/10.1007/bf00052563
Publikováno v:
European journal of pharmacology. 398(1)
Diltiazem has cardioprotective properties following myocardial ischemic injury. However, there are controversial results regarding the beneficial effects of diltiazem on regional myocardial flow after ischemia. Therefore, we investigated the effect o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9be7c954de7d11bc25d47eda32f65c1
https://pubmed.ncbi.nlm.nih.gov/10856451
https://pubmed.ncbi.nlm.nih.gov/10856451
Autor:
Eriko Tanaka, Yoshiaki Takamura, Naoki Katsumata, Taiki Higo, Hiroaki Shimokawa, Tohru Yamawaki, Tadashi Kandabashi, Akira Takeshita, Kenji Yogo, Kenji Miyata, Kensuke Egashira
Publikováno v:
Journal of cardiovascular pharmacology. 35(2)
Serotonin is one of the most important vasoactive substances and has been implicated in the pathogenesis of coronary artery spasm and of acute coronary syndrome. We have recently demonstrated that local and long-term treatment with interleukin-1beta(
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::549990519921d5cc52922a070a0470a7
https://pubmed.ncbi.nlm.nih.gov/10672864
https://pubmed.ncbi.nlm.nih.gov/10672864
Autor:
Kozo Kaibuchi, Akira Takeshita, Kouichi Kuwata, Kensuke Egashira, Naoki Katsumata, Toshiyuki Kozai, Minoru Seto, Hiroaki Shimokawa, Ichiro Ikegaki, Mutsuki Amano, Tadashi Kandabashi, T. Asano, Tohru Yamawaki
Publikováno v:
Cardiovascular research. 43(4)
Objective: We recently demonstrated in our swine model of coronary artery spasm that enhanced myosin light chain (MLC) phosphorylations (both MLC mono- and diphosphorylations) play a central role in the pathogenesis of the spasm. However, the molecul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::076d8397909c6671d855cb070387ffaf
https://pubmed.ncbi.nlm.nih.gov/10615430
https://pubmed.ncbi.nlm.nih.gov/10615430
Autor:
Toshiyuki Kozai, Yasuharu Sasaki, T. Asano, Hiroaki Shimokawa, Ichiro Ikegaki, Kouichi Kuwata, Akira Takeshita, Naoki Katsumata, Tohru Yamawaki, Minoru Seto, Kensuke Egashira
Publikováno v:
Circulation. 96(12)
Background Although coronary artery spasm plays an important role in a wide variety of ischemic heart diseases, the intracellular mechanism for the spasm remains to be clarified. We examined the role of myosin light chain (MLC) phosphorylations, a ke
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4957f46445768f7452ba218e56dec248
https://pubmed.ncbi.nlm.nih.gov/9416877
https://pubmed.ncbi.nlm.nih.gov/9416877
Autor:
Naoki Katsumata, Hiroaki Shimokawa, Kouichi Kuwata, Toshiaki Kadokami, Tohru Yamawaki, Akira Takeshita, Kensuke Egashira, Toshiyuki Kozai, Yoshihiro Fukumoto
Publikováno v:
Coronary artery disease. 8(7)
Background Although platelet activating factor (PAF) is an important vasoactive substance released from activated leukocytes, platelets and endothelial cells, little is known about its effect at the inflammatory coronary lesions in vivo. Objective To
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00657feaced4180ab22b0e70aeb1133a
https://pubmed.ncbi.nlm.nih.gov/9383603
https://pubmed.ncbi.nlm.nih.gov/9383603
Autor:
NAOKI KATSUMATA
Publikováno v:
Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 32:17S-18S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5097b5b40461b6e17a464fad34e1d8b1
https://doi.org/10.3999/jscpt.32.17s
https://doi.org/10.3999/jscpt.32.17s
Autor:
Takaharu Ishibashi, Masayasu Okuhira, Masami Hamaguchi, Naoki Katsumata, Mikio Nakazawa, Shoichi Imai
Publikováno v:
Japanese journal of pharmacology. 55(1)
We studied the effect of carvedilol, a beta-blocker with a potent alpha-blocking activity, on venous return in anesthetized dogs. Though 3 micrograms/kg of carvedilol caused a slight increase in blood pressure and total peripheral resistance, these c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cee68d188f3b3e4b6c10a84da99604c8
https://pubmed.ncbi.nlm.nih.gov/1674971
https://pubmed.ncbi.nlm.nih.gov/1674971
Publikováno v:
Cardiovascular research. 24(12)
Study objective – The aim was to investigate the effects of a newly synthesised bradycardic agent, FR 76830, on cardiac mechanical function and metabolism during ischaemia and reperfusion. Design – FR 76830 and diltiazem were infused during 15 mi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::862ae0c2887fca8a7b3096a2d093f440
https://pubmed.ncbi.nlm.nih.gov/2151429
https://pubmed.ncbi.nlm.nih.gov/2151429